Home › Activist investors › Hudson Executive
Campaign activist. Positions and campaigns from Hudson Executive’s SEC filings. Updated November 20, 2026.
No active campaign by this definition (see How to read this).
No current position by this definition.
Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.
| Company | Outcome or last status | Date | First filing | Highest stage | Filings | Meeting / votes |
|---|---|---|---|---|---|---|
| ViewRay, Inc. | Stake reported below 5% | Jul 21, 2023 | Feb 24, 2020 | — | latest (4) | — |
| eHealth, Inc. | Settled (agreement with the company) | Mar 11, 2021 | Feb 19, 2021 | — | latest (4) | — |
| Cantaloupe, Inc.Board seats | No campaign filings in the last 12 months | Apr 20, 2020 | May 20, 2019 | Proxy contest filed | latest (32) | — |
| Company | Last stake | Source | Outcome | Date |
|---|---|---|---|---|
| Talkspace, Inc. | 0.0% | Schedule 13D/A, filed Aug 17, 2026 | Exited | Aug 17, 2026 |
| Cantaloupe, Inc. | 12.8% | Schedule 13D/A, filed Jun 16, 2025 | Not in the 13F for the quarter ended Jun 30, 2026 | Aug 14, 2026 |
| ViewRay, Inc. | 3.7% | Schedule 13D/A, filed Jul 21, 2023 | Reported below 5% in a 13D/A | Jul 21, 2023 |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
No proxy contest has gone to a vote since July 1, 2023.
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| ViewRay, Inc. | Settlement | agreement with the company | Jan 20, 2023 | Feb 24, 2020 |
| eHealth, Inc. | Settlement | agreement with the company | Jun 7, 2021 | Feb 19, 2021 |
| Cantaloupe, Inc. | No outcome in the filings read | — | Apr 20, 2020 | May 20, 2019 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 3 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.
“…jected based on a failure to satisfy the Observer Qualifications, Hudson shall be entitled, until the earliest to occur of (x) the Expiration Date, (y) the appointment of a Successor Observer in accordance with Section 1(a)(ii) and (z) the appointment of the Observer as a director of the Company in accordance with Section 1(b) , to continue proposing persons as the Successor Observer and any such proposed person shall be promptly installed as the Successor Observer (subject o…” 8-K, Jan 20, 2023
“During the Standstill Period, Hudson shall not, and shall cause its controlling and controlled Affiliates and Associates not to, directly or indirectly, in any manner: (a) purchase or otherwise acquire, or offer, seek, propose or agree to acquire, beneficial ownership of Common Stock such that, giving effect to such purchase or acquisition, Hudson’s beneficial ownership of Common Stock would exceed 14.9% of the Common Stock outstanding;” 8-K, Jan 20, 2023
“…mulgated by the SEC under the Exchange Act of 1934, as amended (together with the rules and regulations thereunder, the “ Exchange Act ”)) or representatives to, appear in person or by proxy at such meeting (or submit written consents) and vote all shares of Common Stock over which Hudson, its Affiliates or Associates has voting power (A) in favor of all directors nominated by the Board for election at any such meeting, (B) in accordance with the Board’s recommendation with r…” 8-K, Jan 20, 2023
“During the Term, the size of the Board will not be more than nine (9) directors; provided , that the size of the Board may be increased to ten (10) directors in connection with the appointment of Sai Nanduri to the Board.” 8-K, Mar 9, 2022
“The Company shall take all necessary actions to promptly appoint such Successor Director to the Board as a Class II director and the applicable committee(s), subject to the approval (not to be unreasonably withheld) of the Nominating and Corporate Governance Committee of the Board, after conducting a good faith and customary process consistent with the Board’s fiduciary duties (and who satisfies the Company Policies applicable to all directors).” 8-K, Mar 9, 2022
“…omulgated by the SEC under the Exchange Act of 1934, as amended (together with the rules and regulations thereunder, the “ Exchange Act ”) or representatives to, appear in person or by proxy at such meeting (or submit written consents) and vote all shares of Common Stock over which Hudson, its Affiliates or Associates has voting power (A) in favor of all directors nominated by the Board for election at any such meeting, (B) in accordance with the Board’s recommendation with r…” 8-K, Mar 9, 2022
Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Hudson Executive’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.
| Holder | Form | Date | Stake |
|---|---|---|---|
| BlackRock, Inc. | Schedule 13G | Oct 17, 2025 | 5.4% |
| MAK Capital Fund LP | Schedule 13G | Mar 2, 2026 | 5.2% |
| Barclays PLC | Schedule 13G | May 14, 2026 | 6.1% |
| Balyasny Asset Management L.P. | Schedule 13G | May 15, 2026 | 5.3% |